GAGNON SECURITIES LLC PCRX — PACIRA BIOSCIENCES INC

Ownership history in GAGNON SECURITIES LLC  ·  35 quarters on record

AI Ownership Summary

GAGNON SECURITIES LLC reported PACIRA BIOSCIENCES INC (PCRX) in 35 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 4.42% in 2023 Q4. The latest visible filing shows PCRX at 3.22% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this PCRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was GAGNON SECURITIES LLC's position in PACIRA BIOSCIENCES INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

PCRX was reported at 3.22% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
4.42% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

PCRX stock page GAGNON SECURITIES LLC fund profile GAGNON SECURITIES LLC full holdings
How GAGNON SECURITIES LLC held PCRX — position size vs. price
% of Fund (quarterly)    PCRX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED — — — 617,510 +116,299 +23.2% 3.22% $14.0M 2026-04-22 $24.88
2025 Q4 ADDED — — — 501,211 +51,494 +11.5% 2.64% $13.0M 2026-02-13 $21.77
2025 Q3 ADDED — — — 449,717 +81,364 +22.1% 2.32% $11.6M 2025-11-03 $22.19
2025 Q2 ADDED — — — 368,353 +60,019 +19.5% 1.79% $8.8M 2025-07-23 $22.25
2025 Q1 REDUCED — — — 308,334 -13,409 -4.2% 1.69% $7.7M 2025-05-09 $25.12
2024 Q4 ADDED — — — 321,743 +14,800 +4.8% 1.22% $6.1M 2025-01-24 $24.52
2024 Q3 REDUCED 48.6% +25.9% ❌ 306,943 -289,648 -48.6% 0.92% $4.6M 2024-11-12 $16.80
2024 Q2 ADDED — — — 596,591 +47,623 +8.7% 3.84% $17.1M 2024-08-14 $12.47
2024 Q1 ADDED — — — 548,968 +3,389 +0.6% 3.80% $16.0M 2024-05-13 $30.38
2023 Q4 REDUCED — — — 545,579 -19,850 -3.5% 4.42% $18.4M 2024-02-14 $29.23
25 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding PCRX

As of 2026 Q1 — sorted by position size

Doma Perpetual Capital Management LLC 16.86% Gagnon Advisors, LLC 3Y 7Y 5.86% Bridge City Capital, LLC 3Y 7Y 2.52% Lion Point Capital, LP 3Y 7Y 1.82% EASTERLY INVESTMENT PARTNERS LLC 3Y 7Y 0.59% Phocas Financial Corp. 3Y 7Y 0.41% Three Seasons Wealth, LLC 0.38% MILESTONE ASSET MANAGEMENT, LLC 3Y 0.25% Hillsdale Investment Management Inc. 3Y 7Y 0.2% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.19%

FAQ About GAGNON SECURITIES LLC and PCRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has GAGNON SECURITIES LLC reported owning PCRX?

GAGNON SECURITIES LLC reported PCRX across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported PCRX position in GAGNON SECURITIES LLC's portfolio?

The largest reported portfolio weight for PCRX was 4.42% in 2023 Q4.

What is the latest reported PCRX position on this page?

The most recent filing on this page is 2026 Q1, when GAGNON SECURITIES LLC reported 617,510 shares, equal to 3.22% of portfolio, with an estimated market value of $14.0M.

What does the chart on this PCRX ownership page compare?

The chart compares GAGNON SECURITIES LLC's quarterly PCRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did GAGNON SECURITIES LLC time their PCRX position?

Based on 13F filing dates vs. subsequent PCRX price moves, GAGNON SECURITIES LLC correctly timed 17 out of 27 reported position changes (63%). The annualised alpha on PCRX relative to SPY over the holding period was -19.9%.

← Back to GAGNON SECURITIES LLC Holdings